AQR Capital Management - ASSERTIO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$2,282,000
-44.3%
3,510,451
+7.2%
0.00%
-20.0%
Q4 2019$4,095,000
+111.3%
3,276,029
+116.3%
0.01%
+150.0%
Q3 2019$1,938,000
+22.7%
1,514,369
+230.6%
0.00%0.0%
Q2 2019$1,580,000
-33.8%
458,062
-2.6%
0.00%
-33.3%
Q1 2019$2,385,000
+46.9%
470,425
+4.6%
0.00%
+50.0%
Q4 2018$1,624,000
+16.4%
449,735
+89.6%
0.00%
+100.0%
Q3 2018$1,395,000237,2150.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 3,278,000$11,834,0000.90%
Senvest Management, LLC 2,124,393$7,669,0000.66%
DELTEC ASSET MANAGEMENT LLC 351,176$1,268,0000.35%
PERKINS CAPITAL MANAGEMENT INC 99,600$360,0000.28%
Matarin Capital Management, LLC 838,619$3,027,415,0000.24%
GLOBEFLEX CAPITAL L P 196,357$709,0000.17%
Opaleye Management Inc. 120,000$433,0000.16%
TSP Capital Management Group, LLC 49,175$178,0000.10%
Spark Investment Management LLC 373,609$1,348,0000.09%
Connor, Clark & Lunn Investment Management Ltd. 3,191,964$11,523,0000.08%
View complete list of ASSERTIO THERAPEUTICS INC shareholders